학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 411건 | 목록 1~10
Conference
The 2004 IEEE Asia-Pacific Conference on Circuits and Systems, 2004. Proceedings. Circuits and systems Circuits and Systems, 2004. Proceedings. The 2004 IEEE Asia-Pacific Conference on. 2:637-640 vol.2 2004
Academic Journal
Bando K; Regenerative & Cellular Medicine Office, Sumitomo Pharma Co., Ltd., Kobe, Japan; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan. Electronic address: kiyoko.bando@sumitomo-pharma.co.jp.; Kusakawa S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Japan.; Adachi H; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Preclinical Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan.; Yamamoto M; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Non-clinical Biomedical Science, Astellas Pharma Inc., Tsukuba, Japan.; Iwata M; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Osaka Laboratory (formerly the Technology Innovation Center), Sumika Chemical Analysis Service Ltd., Osaka, Japan.; Kitanaka A; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Osaka Laboratory (formerly the Technology Innovation Center), Sumika Chemical Analysis Service Ltd., Osaka, Japan.; Ogimura E; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Preclinical Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan.; Osada T; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Advanced Medical Business Development Department, Mediford Corporation, Tokyo, Japan.; Tamura M; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Safety Business Unit (formerly Integrated & Translational Science), Axcelead Drug Discovery Partners Inc., Fujisawa, Japan.; Terai O; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Osaka Laboratory (formerly the Technology Innovation Center), Sumika Chemical Analysis Service Ltd., Osaka, Japan.; Watanabe T; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Drug Safety Research and Evaluation, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.; Yoda T; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Preclinical Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan.; Yotsumoto T; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Medicinal Safety Research Laboratories, Daiichi Sankyo Company Limited, Tokyo, Japan.; Zaizen K; The Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-Derived Product, Forum for Innovative Regenerative Medicine, Tokyo, Japan; Kumamoto Laboratories, Mediford Corporation, Kumamoto, Japan.; Sato Y; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Japan; Division of Drugs, National Institute of Health Sciences, Kawasaki, Japan.
Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Conference
2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC) Nuclear Science Symposium Conference Record (NSS/MIC), 2009 IEEE. :1257-1258 Oct, 2009
Academic Journal
IEEE Transactions on Magnetics IEEE Trans. Magn. Magnetics, IEEE Transactions on. 39(5):2489-2491 Sep, 2003
Conference
Proceedings of 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society Engineering in medicine and biology Engineering in Medicine and Biology Society, 1996. Bridging Disciplines for Biomedicine. Proceedings of the 18th Annual International Conference of the IEEE. 1:150-151 vol.1 1996
Academic Journal
Miura T; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan.; Kouno T; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Takano M; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Kuroda T; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Yamamoto Y; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Kusakawa S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Morioka MS; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Sugawara T; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan.; Biopharmaceutical and Regenerative Sciences, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.; Hirai T; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Yasuda S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Sawada R; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Matsuyama S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Center for Reverse TR, Osaka Habikino Medical Center, Osaka Prefectural Hospital Organization, Osaka, Japan.; Kawaji H; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.; Kasukawa T; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Itoh M; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Matsuyama A; Center for Reverse TR, Osaka Habikino Medical Center, Osaka Prefectural Hospital Organization, Osaka, Japan.; Shin JW; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Genomic Institute of Singapore, Agency for Science, Technology and Research, Singapore.; Umezawa A; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan.; Kawai J; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Life Science Technology Project, Kanagawa Institute of Industrial Science and Technology, Kawasaki, Japan.; Sato Y; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kanagawa, Japan.; Life Science Technology Project, Kanagawa Institute of Industrial Science and Technology, Kawasaki, Japan.; Department of Cellular and Gene Therapy Products, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101578022 Publication Model: Print Cited Medium: Internet ISSN: 2157-6580 (Electronic) Linking ISSN: 21576564 NLM ISO Abbreviation: Stem Cells Transl Med Subsets: MEDLINE
Academic Journal
Sen'i Gakkaishi. 1994, 50(5):188
Academic Journal
Watanabe T; Drug Safety Research & Evaluation, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.; Yasuda S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.; Chen CL; Health & Environmental Sciences Institute, 740 Fifteenth Street NW, Suite 600, Washington, DC 20005, USA.; Delsing L; CVRM Safety, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 43150, Sweden.; Fellows MD; CVRM Safety, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Darwin Building 310, Milton Science Park, Cambridge, CB4 OWG, UK.; Foldes G; National Heart & Lung Institute, Imperial College London, London, W120NN, UK.; Current address, BioPharmaceuticals R&D, AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.; Kusakawa S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.; Mouriès LP; Health & Environmental Sciences Institute, 740 Fifteenth Street NW, Suite 600, Washington, DC 20005, USA.; Sato Y; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.
Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101278116 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1746-076X (Electronic) Linking ISSN: 17460751 NLM ISO Abbreviation: Regen Med Subsets: MEDLINE
Academic Journal
Kusakawa S; Nagoya Institute of Technology, Showa-ku, Nagoya, Aichi, 466-8555, Japan kusakawa.s.mllab.nit@gmail.com.; Takeno S; Nagoya Institute of Technology, Showa-ku, Nagoya, Aichi, 466-8555, Japan takeno.s.mllab.nit@gmail.com.; Inatsu Y; Nagoya Institute of Technology, Showa-ku, Nagoya, Aichi, 466-8555, Japan inatsu.yu@nitech.ac.jp.; Kutsukake K; RIKEN Center for Advanced Intelligent Project, Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.; Nagoya University, Chikusa-ku, Nagoya 464-8603, Japan kentaro.kutsukake@riken.jp.; Iwazaki S; Nagoya Institute of Technology, Showa-ku, Nagoya, Aichi, 466-8555, Japan iwazaki.s.mllab.nit@gmail.com.; Nakano T; Nagoya University, Chikusa-ku, Nagoya 464-8603, Japan nakano.t@unno.material.nagoya-u.ac.jp.; Ujihara T; Nagoya University, Chikusa-ku, Nagoya 464-8603, Japan ujihara@nagoya-u.jp.; Karasuyama M; Nagoya Institute of Technology, Showa-ku, Nagoya, Aichi, 466-8555, Japan karasuyama@nitech.ac.jp.; Takeuchi I; RIKEN Center for Advanced Intelligent Project, Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.; Nagoya University, Chikusa-ku, Nagoya 464-8603, Japan ichiro.takeuchi@mae.nagoya-u.ac.jp.
Publisher: MIT Press Country of Publication: United States NLM ID: 9426182 Publication Model: Print Cited Medium: Internet ISSN: 1530-888X (Electronic) Linking ISSN: 08997667 NLM ISO Abbreviation: Neural Comput Subsets: PubMed not MEDLINE; MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Kusakawa, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어